China's NMPA and Singapore's HSA Sign Regulatory Cooperation Memorandum on May 11

China's National Medical Products Administration and Singapore's Health Sciences Authority signed a regulatory cooperation memorandum of understanding yesterday (May 11), according to the NMPA. The agreement was signed between NMPA Director Huang Guo and Singapore's Health Sciences Authority Director Cai Ruiwen. The two parties discussed regulatory frameworks for cell and gene therapies, innovative medical devices, and artificial intelligence-based healthcare products.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments